Intellia Therapeutics' IPO

Intellia Therapeutics raised a round of funding on May 06, 2016. Investors include Public.

Intellia Therapeutics is a gene-editing company focused on the development of proprietary products utilizing the recently discovered CRISPR/Cas9 technology. Intellia intends to advance its pipeline an…

Articles about Intellia Therapeutics' IPO: